License agreement with Medicine Patent Pool will speed clinical development of drug considered promising for improved treatment of tuberculosis responsive and resistant to existing drugs With all regimens to treat tuberculosis requiring multiple drugs, and all but two of those drugs tracing their lineage to the middle of the last century, excitement was high in […]
HIV
The following is a guest post by Emily Bobrow, PhD, of MEASURE Evaluation A combination of integrated service delivery approaches for mothers who are living with […]
Tuberculosis
Combatting MDR TB: Year three – Released four years ago, the federal National Action Plan for Combating Multidrug-Resistant Tuberculosis raised hopes that targets and strategies would […]
Research & Development
This year marks the close of a dynamic decade in global infectious disease research and responses that changed expectations of what humanity can accomplish toward making […]
Policy
The following is a guest post by Jeffrey Duchin, MD, FIDSA The quarantine and travel restrictions announced by the US federal government in response to the […]